Concuss Pharmaceuticals Private Limited
About Concuss Pharmaceuticals Private Limited
Data last updated:
Concuss Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the diversified business activities segment of the business services sector. It was incorporated on 31 July 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74999DL2017PTC321472. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Vinoda Rai (Managing Director) and Ravi Rai.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at Shop No. 1 Lower Ground Floor Plot No. B – 15 Kiran Garden Matiala Road Uttam Nagar, New Delhi, Delhi, India – 110059.
As per the financials filed for FY 2020, the company reported a revenue of ₹47,995, a decline of 99% compared to the previous year. For the same year it recorded a net loss of ₹98,867 (net margin -206%) and EBITDA of -₹35,529 (EBITDA margin -74%).
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Concuss Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Registered AddressShop No. 1 Lower Ground Floor Plot No. B – 15 Kiran Garden Matiala Road Uttam Nagar, New Delhi, Delhi, India – 110059
- IndustryBusiness Services, Miscellaneous Business Activities, Other Services
To see the full contact details of Concuss Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Concuss Pharmaceuticals Private Limited
FY 2023 filings availableConcuss Pharmaceuticals Private Limited reported revenue of ₹47,995 (down 99% YoY) for FY 2020.
Compounded Annual Growth Rate (CAGR)
Revenue fell 99% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | ₹47,995 | ||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | -₹35,529 | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | -₹98,867 | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | -74% | ||
| Net Profit Margin | -206% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Concuss Pharmaceuticals Private Limited, buy the company report.
Board of directors of Concuss Pharmaceuticals Private Limited
Concuss Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vinoda Rai | Managing Director | 31 Jul 2017 | 9 Years 2 Months | Current |
| Ravi Rai | Additional Director | 28 Feb 2018 | 8 Years 7 Months | Current |
Legal cases
No court or tribunal cases involving Concuss Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Concuss Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Concuss Pharmaceuticals has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Concuss Pharmaceuticals Private Limited, buy the company report.
Recent activity
Concuss Pharmaceuticals Private Limited has 3 board changes on record since 2017: 2 appointments and 1 cessation. The latest: Deepa Rasaily ceased to be Director on 28 Feb 2018.
Frequently asked questions
Concuss Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in miscellaneous business activities, within the business services industry. It was incorporated on 31 July 2017 (9+ years old) and is registered under CIN U74999DL2017PTC321472.
Concuss Pharmaceuticals has 2 current directors:
- Vinoda Rai - Managing Director
- Ravi Rai - Additional Director
The latest financial statements of Concuss Pharmaceuticals on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from FY 2018 are in the company report.
No. Concuss Pharmaceuticals has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Concuss Pharmaceuticals is U74999DL2017PTC321472. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Concuss Pharmaceuticals was incorporated on 31 July 2017, making it 9+ years old. It is registered with the Registrar of Companies, Delhi.
Deepa Rasaily ceased to be Director on 28 Feb 2018. Ravi Rai was appointed as Additional Director on 28 Feb 2018. Vinoda Rai was appointed as Managing Director on 31 Jul 2017.
The registered office of Concuss Pharmaceuticals is at Shop No. 1 Lower Ground Floor Plot No. B – 15 Kiran Garden Matiala Road Uttam Nagar, New Delhi, Delhi, India – 110059.
Concuss Pharmaceuticals operates in the business services industry, in the miscellaneous business activities segment.
The compliance status of Concuss Pharmaceuticals is compliant as of 07 September 2026. The company is actively filing with the Registrar of Companies.